Inactive Instrument

Analyst Reco. BIO-TECHNE Corp Nasdaq

Equities

US8783771004

End-of-day quote Nasdaq Other stock markets
- ^USD	-

05-22	Citigroup Downgrades Bio-Techne to Neutral From Buy, With $85 Price Target	MT
05-16	Bio-techne Insider Sold Shares Worth $335,377, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Citigroup Downgrades Bio-Techne to Neutral From Buy, With $85 Price Target	05-22	MT
Bio-techne Insider Sold Shares Worth $335,377, According to a Recent SEC Filing	05-16	MT
Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating	05-06	MT
UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating	05-02	MT
Leerink Partners Adjusts Price Target on Bio-Techne to $95 From $85	05-02	MT
Scotiabank Adjusts Price Target on Bio-Techne to $83 From $80	05-02	MT
RBC Capital Adjusts Price Target on Bio-Techne to $72 From $71, Sector Perform Rating Kept	05-02	MT
Baird Adjusts Bio-Techne Price Target to $81 From $73	05-02	MT
Deutsche Bank Adjusts Price Target on Bio-Techne to $84 From $82	05-01	MT
RBC Capital Adjusts Price Target on Bio-Techne to $71 From $79	04-29	MT
Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85	04-18	MT
RBC Raises Price Target on Bio-Techne to $79 From $75, Keeps Sector Perform Rating	04-08	MT
Stephens Adjusts Bio-Techne's Price Target to $87 From $70, Keeps Overweight Rating	02-02	MT
Deutsche Bank Cuts Bio-Techne Price Target to $85 From $88, Maintains Buy Rating	02-02	MT
RBC Cuts Price Target on Bio-Techne to $75 From $85, Notes Revenue Growth Turned Negative, Keeps Sector Perform Rating	02-02	MT
Stifel Nicolaus Downgrades Bio-Techne to Hold from Buy, $65 Price Target	02-02	MT
UBS Initiates Coverage on Bio-Techne With Buy Rating, $80 Price Target	12-07	MT
Deutsche Bank Cuts Bio-Techne Price Target to $70 From $100, Maintains Buy Rating	11-01	MT
KeyBanc Cuts Price Target on Bio-Techne to $80 From $115, Maintains Overweight Rating	11-01	MT
RBC Trims Price Target on Bio-Techne to $83 From $85, Keeps Sector Perform Rating	11-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. BIO-TECHNE Corp Nasdaq

Equities

US8783771004

Analyst Reco.

Filters